Description:
PTM Therapeutics is striving to discover new targets and develop new therapeutics for the treatment of chronic diseases and cancer by targeting post-translational modifications. The company mainly focused on therapeutics discovery for the treatment of inflammatory bowel disease. PTM's lead antibody, PTM-001 targets the inflammed gut epithelium and promotes mucosal healing.